Navigation Links
RBC Life Sciences' North American Nutritional Supplements and Medical Products Sales Increased, Year Over Year, During the First Quarter of 2009
Date:5/8/2009

ms in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange.


                             RBC Life Sciences, Inc.
                          Summary Results of Operations
                       (in thousands, except per share data)
                                 (unaudited)

                                                 Quarters Ended March 31,
                                                   2009          2008

     Net sales                                   $6,016        $6,348
     Gross profit                                 3,139         3,503
     Operating profit (loss)                       (161)          612
     Earnings (loss) before income taxes           (203)          567
     Provision (benefit) for income taxes           (32)          212
     Net earnings (loss)                           (171)          355

     Earnings (loss) per share - basic and
      diluted                                    $(0.01)        $0.02

     Weighted average shares outstanding -
       basic                                     21,917        21,114
     Weighted average shares outstanding -
      diluted                                    21,917        22,573



                             RBC Life Sciences, Inc.
                            Condensed Balance Sheets
                                 (in thousands)
                                  (unaudited)

                                                 March 31,   December 31,
                                                    2009         2008
     Assets
     Cash and cash equivalents                     $5,631       $4,973
     Inventories                                    5,202        5,707
     Other current assets                           2,467        2,245
       Tot
'/>"/>
SOURCE RBC Life Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
2. Edwards Lifesciences to Present at the Bear Stearns 20th Annual Healthcare Conference
3. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
4. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
5. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
6. Novavax CEO to Present at the 2007 UBS Global Life Sciences Conference
7. Cardiac Science to Present at the UBS Global Life Sciences Conference
8. Akers Biosciences, Inc. ABI or the Company Receipt of Further United States Military Contracts
9. DRAXIS to Present at the 2007 UBS Global Life Sciences Conference
10. ViroPharma to Present at the UBS Global Life Sciences Conference
11. Clarient to Present at the UBS 2007 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... By Maureen Salamon ... (HealthDay News) -- For the millions of women who ... researchers are testing a treatment that uses stem cells ... pilot study, European researchers found that injecting stem cells ... stress incontinence in all participants within a year. ...
(Date:7/11/2014)... the era of personalized medicine may be just around ... Cell researcher Min Yu and scientists at Massachusetts General ... 11 study in Science , Yu and her ... through the blood streams of six patients. Some of ... which travel to and establish secondary tumors in vital ...
(Date:7/11/2014)... OR (PRWEB) July 11, 2014 Recent research ... life, health, the atmosphere, and how water affects human bodies. ... Water, Gerald Pollack, during an interview on the Sharon Kleyne ... , Gerald Pollack, PhD, is a Professor ... is The Fourth Phase of Water (Ebner & Sons, 2013). ...
(Date:7/11/2014)... 2014 Cancer researchers in Slovenia say ... impact on how patients respond to treatment with pemetrexed ... Mesothelioma has the full story. Click here to ... the University of Ljubljana and the Ljubljana Institute of ... different types of polymorphisms. They found that patients with ...
(Date:7/11/2014)... 11, 2014 Shoulder instability is a ... return to play has not been regularly determined following ... Society for Sports Medicine’s ( AOSSM ) Annual Meeting ... approximately 90 percent no matter what the stabilization procedure ... rate of return to play following shoulder stabilization surgery. ...
Breaking Medicine News(10 mins):Health News:Stem Cells May Ease Urinary Incontinence, Study Says 2Health News:Stem Cells May Ease Urinary Incontinence, Study Says 3Health News:Recent Fourth Phase Water Discoveries Alter Basic Understanding of Life, Claims Researcher on Sharon Kleyne Hour 2Health News:Recent Fourth Phase Water Discoveries Alter Basic Understanding of Life, Claims Researcher on Sharon Kleyne Hour 3Health News:New Research Finds Genetic Variables Impact Chemotherapy Response, According to Surviving Mesothelioma 2Health News:Stabilizing Shoulder Surgery Helps NFL Players Return to the Game 2
... April 16 The California Dental Association ... is rapidly approaching to have your kindergartener receive a ... school year.The requirement has been in effect for two ... chronic childhood disease, it is essential that children develop ...
... April 16 The 6th annual North Carolina "Give Kids ... children being treated across the state, a 26% increase over ... increase of $710,000 (56%) compared to last year. The event ... assistants and other volunteers took part in the program, which ...
... could keep them younger, longer , , THURSDAY, April 16 ... insights into how cells and tissues may stay youthful ... by cells to stay alive when oxygen levels are ... defend against some age-related diseases, a new study finds. ...
... gallons of bottled water were consumed in 2000, an increase ... consumers drink more bottled water because it is an alternative ... is unclear, but one thing is certain: they are missing ... helps to protect teeth from cavities, according to a study ...
... & Conference Track will Offer Attendees the Latest Resources ... April 16 With consumers paying closer attention to ... private label and contract manufacturer resources, the new Private ... a hotbed of activity. Taking place September 15-17, ...
... Service hospitals, usage by stroke rehab patients dictates increase ... Saebo, Inc. announced in its first quarter that its ... 2008 and has added staff to accommodate its continued ... Saebo UK," said UK Managing Director, Glyn Blakey. "In ...
Cached Medicine News:Health News:California Dental Association Reminds Parents of Kindergarten Dental Check-Up Requirement 2Health News:Worms Reveal More of Longevity's Secrets 2Health News:Parents: Bottled Water Trend Poses Threat to Dental Health 2Health News:Parents: Bottled Water Trend Poses Threat to Dental Health 3Health News:HBA Global Expo Platforms Private Label/Contract Manufacturing 2Health News:HBA Global Expo Platforms Private Label/Contract Manufacturing 3Health News:Saebo United Kingdom Posts Record 2008; Sees Continued Growth in UK for 2009 2
(Date:7/11/2014)... 11, 2014 Research and Markets ( ... "Immunoprotein Diagnostic Testing Market - Forecasts to ... of 6% and is expected to be valued ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... has been segmented according to immunoprotein types which ...
(Date:7/11/2014)... SAN DIEGO , July 11, 2014 ... Therapies Corp. ("Biotie") to end the option held by ... to commence further development of NRL-1 (intranasal diazepam) for ... seizures. Over the past year, Biotie has ... Neurelis in preparation for the pivotal clinical work required ...
(Date:7/10/2014)... 2014  The U.S. Department of Health and Human ... Hospitals (UH) Case Medical Center Seidman Cancer Center totaling ... at improving care for patients with complex cancer. ... test a unique model developed at UH to enhance ... comorbidities, or demonstrated need for high health care utilization.  ...
Breaking Medicine Technology:Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million 2Neurelis Regains Rights to Intranasal Diazepam Program 2Neurelis Regains Rights to Intranasal Diazepam Program 3University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 2University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 3University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 4
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
Medicine Products: